222 related articles for article (PubMed ID: 24937430)
1. Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth.
Knelson EH; Gaviglio AL; Nee JC; Starr MD; Nixon AB; Marcus SG; Blobe GC
J Clin Invest; 2014 Jul; 124(7):3016-31. PubMed ID: 24937430
[TBL] [Abstract][Full Text] [Related]
2. Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiation.
Gaviglio AL; Knelson EH; Blobe GC
FASEB J; 2017 May; 31(5):1903-1915. PubMed ID: 28174207
[TBL] [Abstract][Full Text] [Related]
3. Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.
Knelson EH; Gaviglio AL; Tewari AK; Armstrong MB; Mythreye K; Blobe GC
J Clin Invest; 2013 Nov; 123(11):4786-98. PubMed ID: 24216509
[TBL] [Abstract][Full Text] [Related]
4. Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model.
Zhang Z; Coomans C; David G
J Biol Chem; 2001 Nov; 276(45):41921-9. PubMed ID: 11551944
[TBL] [Abstract][Full Text] [Related]
5. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
Krufka A; Guimond S; Rapraeger AC
Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro degradation of heparan sulfate (HS) proteoglycans by HPR1 in pancreatic adenocarcinomas. Loss of cell surface HS suppresses fibroblast growth factor 2-mediated cell signaling and proliferation.
Xu X; Rao G; Quiros RM; Kim AW; Miao HQ; Brunn GJ; Platt JL; Gattuso P; Prinz RA
J Biol Chem; 2007 Jan; 282(4):2363-73. PubMed ID: 17121850
[TBL] [Abstract][Full Text] [Related]
8. Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo.
Li H; Wang Y; Chen Z; Lu J; Pan J; Yu Y; Zhao Y; Zhang H; Hu T; Liu Q; Yang J
Oncotarget; 2017 Jan; 8(4):5874-5884. PubMed ID: 27564113
[TBL] [Abstract][Full Text] [Related]
9. Testosterone-induced growth of S115 mouse mammary tumor cells is dependent on heparan sulfate.
Borgenström M; Tienhaara A; Spillmann D; Salmivirta M; Jalkanen M
Exp Cell Res; 2001 Apr; 264(2):307-14. PubMed ID: 11262187
[TBL] [Abstract][Full Text] [Related]
10. Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.
Rusnati M; Coltrini D; Caccia P; Dell'Era P; Zoppetti G; Oreste P; Valsasina B; Presta M
Biochem Biophys Res Commun; 1994 Aug; 203(1):450-8. PubMed ID: 8074689
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells.
Borriello L; Nakata R; Sheard MA; Fernandez GE; Sposto R; Malvar J; Blavier L; Shimada H; Asgharzadeh S; Seeger RC; DeClerck YA
Cancer Res; 2017 Sep; 77(18):5142-5157. PubMed ID: 28687621
[TBL] [Abstract][Full Text] [Related]
12. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action.
Jones M; Tussey L; Athanasou N; Jackson DG
J Biol Chem; 2000 Mar; 275(11):7964-74. PubMed ID: 10713114
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effect of syndecan ectodomains and N-desulfated heparins on osteoclastogenesis via direct binding to macrophage-colony stimulating factor.
Kim JM; Lee K; Kim MY; Shin HI; Jeong D
Cell Death Dis; 2018 Nov; 9(11):1119. PubMed ID: 30389911
[TBL] [Abstract][Full Text] [Related]
15. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican.
Steinfeld R; Van Den Berghe H; David G
J Cell Biol; 1996 Apr; 133(2):405-16. PubMed ID: 8609172
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
[TBL] [Abstract][Full Text] [Related]
18. Similarities and differences between the effects of heparin and glypican-1 on the bioactivity of acidic fibroblast growth factor and the keratinocyte growth factor.
Berman B; Ostrovsky O; Shlissel M; Lang T; Regan D; Vlodavsky I; Ishai-Michaeli R; Ron D
J Biol Chem; 1999 Dec; 274(51):36132-8. PubMed ID: 10593896
[TBL] [Abstract][Full Text] [Related]
19. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.
Ling L; Tan SK; Goh TH; Cheung E; Nurcombe V; van Wijnen AJ; Cool SM
Mol Cancer; 2015 Jul; 14():136. PubMed ID: 26201468
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans.
van der Voort R; Keehnen RM; Beuling EA; Spaargaren M; Pals ST
J Exp Med; 2000 Oct; 192(8):1115-24. PubMed ID: 11034601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
